Forest Labs to pay $38M for False Claims Act violations

Forest Laboratories and its subsidiary, Forest Pharmaceuticals, have agreed to pay $38 million to resolve allegations that they violated the False Claims Act by paying kickbacks to induce physicians to prescribe its drugs. Jaclyn Jaeger has more.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.